Idenix Pharmaceuticals to Present at Three Upcoming Healthcare Conferences
May 08 2013 - 4:05PM
Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that
Idenix management will present a corporate overview at the Bank of
America Merrill Lynch 2013 Health Care Conference on Wednesday, May
15, 2013 at 11:20 a.m. PT at the Encore at the Wynn in Las Vegas,
NV; and at the UBS Global Healthcare Conference on Tuesday, May 21,
2013 at 8:00 a.m. ET at the Sheraton New York Hotel in New York,
NY. Management will also host a fireside chat discussion at
the Deutsche Bank Securities 38th Annual Health Care Conference on
Thursday, May 30, 2013 at 1:30 p.m. ET at the Westin Boston
Waterfront Hotel in Boston, MA.
The live and archived webcasts of the company presentations can
be accessed under "Events and Presentations" in the Idenix Investor
Center at www.idenix.com. Please log in approximately 5-10
minutes before each event to ensure a timely connection. The
archived replay will be available on the Idenix website for two
weeks following the conferences.
ABOUT IDENIX
Idenix Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is a biopharmaceutical Company engaged in the
discovery and development of drugs for the treatment of human viral
diseases. Idenix's current focus is on the treatment of patients
with hepatitis C infection. For further information about Idenix,
please refer to www.idenix.com.
CONTACT: Idenix Pharmaceuticals Contact:
Teri Dahlman
(617) 995-9807
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024